查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2038777

對 2026 年至 2035 年抽脂設備市場的商業機會、成長要素、產業趨勢和預測進行分析。

Liposuction Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球抽脂設備市場預計到 2025 年將價值 10 億美元，預計到 2035 年將以 9.7% 的複合年成長率成長至 26 億美元。

抽脂設備市場-IMG1

市場擴張的促進因素包括：人們對微創美容手術的偏好日益成長、文明病發病率上升、能量和抽吸技術的不斷進步，以及尋求塑形治療的老年人口穩步成長。此外，患者對更快恢復、更高安全性和更自然效果的期望也在重塑市場需求趨勢。將雷射、超音波和射頻等先進能量技術整合到抽脂系統中，可提高手術精度和治療效果，同時減少組織損傷和恢復時間。醫院、美容診所和門診手術中心對塑形手術的日益普及進一步提升了市場滲透率。人們對結合減脂和緊膚的聯合療法的興趣日益濃厚，也拓展了臨床應用範圍。此外，人們對美容健康的日益重視以及醫療保健服務的改善，促使更多人選擇進行塑形治療，從而增強了整體市場成長勢頭。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 10億美元
預測金額 26億美元
複合年成長率 9.7%

截至2025年，獨立式系統市佔率將達到65.4%。這些系統因其能夠在複雜的體型雕塑手術中提供穩定精準的效果，而被廣泛應用於醫院和大規模整形外科中心。這些機構擁有先進的臨床基礎設施、經驗豐富的醫療專業人員以及強大的患者處理能力，極大地推動了其應用。獨立式設備提供更精準的手術控制、更完善的安全功能和更強大的監測能力，使其能夠滿足複雜的手術需求。持續的技術升級進一步提升了設備的效率、可靠性和整體穩定性，鞏固了其在市場上的領先地位。

預計到2025年，抽脂術市場規模將達到2.851億美元。由於其臨床可靠性高、操作簡便且效果可預測，該技術仍然是最廣泛使用的方法之一。透過連接真空系統的套管進行手動消脂，使其成為美容消脂領域值得信賴的方法。多年的臨床應用提高了外科醫生的熟練程度，降低了訓練難度，並確保了效果的穩定性。其成本效益和操作簡便性也使其在尋求可靠且經濟的塑形方案的醫療機構中得到廣泛認可。

預計到2025年，北美抽脂設備市佔率將達到33.1%。該地區市場成長的主要驅動力是肥胖症的日益流行，尤其是在美國，這推動了對消脂需求的成長。人們對身體美的日益關注、對肥胖相關健康風險的擔憂以及生活方式改善的趨勢也促進了市場擴張。這種對健康和美容改善日益成長的興趣，加上完善的醫療基礎設施和先進的外科技術，將繼續支撐該地區對抽脂手術需求的持續成長。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性協議
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 人們越來越傾向微創手術
      • 慢性病盛行率增加
      • 抽脂設備技術的快速發展
      • 人口老化的進程
    • 產業潛在風險與挑戰
      • 對替代治療方法的認知度低且缺乏相關資源
      • 高昂的醫療費用
    • 市場機遇
      • 新興市場採用率的擴大
      • 抽脂與皮膚緊緻/塑形技術的結合
  • 成長潛力分析
  • 監理情勢（基於初步調查）
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
      • 以能量為基礎的微創抽脂系統（射頻、雷射、超音波輔助）
      • 動力輔助功能和符合人體工學的最佳化抽脂平台
    • 新興技術
      • 人工智慧驅動的治療計劃和即時手術監測
      • 智慧、互聯、多功能抽脂設備
  • 未來市場趨勢（基於初步研究）
  • 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
  • 2025年價格分析
  • 波特五力分析
  • PESTEL 分析

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 北美洲
    • 歐洲
    • 亞太地區
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

  • 獨立型
  • 可攜式的

第6章 市場估計與預測：依技術分類，2022-2035年

  • 腫脹麻醉抽脂手術
  • 超音波輔助抽脂術（UAL）
  • 雷射輔助抽脂手術（LAL）
  • 動力輔助抽脂術（PAL）
  • 體部噴射或液壓抽脂術 (WAL)
  • 抽脂手術（SAL）
  • 其他技術

第7章 市場估計與預測：依最終用途分類，2022-2035年

  • 醫院
  • 診所
  • 整形外科中心
  • 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • 博士倫健康公司
  • Cynosure
  • Euromi
  • Human Med AG
  • InMode
  • INTERmedic Arfran
  • INVAMED
  • Johnson &Johnson
  • LHbiomed
  • MicroAire
  • MOLLER Medical GmbH
  • NOUVAG AG
  • Sciton
  • Sisram Medical
  • Vitruvian Partners
簡介目錄
Product Code: 6459

The Global Liposuction Devices Market was valued at USD 1 billion in 2025 and is estimated to grow at a CAGR of 9.7% to reach USD 2.6 billion by 2035.

Liposuction Devices Market - IMG1

Market expansion is supported by the increasing preference for minimally invasive aesthetic procedures, the rising incidence of chronic lifestyle-related conditions, ongoing advancements in energy-based and suction technologies, and the steady growth of the geriatric population seeking body contouring treatments. In addition, evolving patient expectations for faster recovery, improved safety, and natural-looking results are reshaping the demand landscape. The integration of advanced energy modalities such as laser, ultrasound, and radiofrequency into liposuction systems is enhancing procedural precision and outcomes while reducing tissue trauma and downtime. Growing adoption of body sculpting procedures across hospitals, cosmetic clinics, and ambulatory surgical centers is further reinforcing market penetration. The increasing emphasis on combination procedures that merge fat reduction with skin tightening is also expanding clinical applications. Furthermore, rising awareness regarding aesthetic wellness and improvements in healthcare accessibility are encouraging more individuals to opt for elective body contouring procedures, thereby strengthening overall market growth momentum.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$ 1 Billion
Forecast Value$2.6 Billion
CAGR9.7%

The standalone systems segment held a 65.4% share in 2025. These systems are widely utilized in hospitals and high-volume cosmetic surgery centers due to their ability to deliver consistent and precise outcomes in complex body contouring procedures. Their adoption is strongly supported by the availability of advanced clinical infrastructure, experienced medical professionals, and high patient throughput in such facilities. Standalone devices offer enhanced procedural control, improved safety features, and better monitoring capabilities, making them suitable for intricate surgical requirements. Continuous technological upgrades have further improved device efficiency, reliability, and overall treatment consistency, reinforcing their strong position in the market.

The suction-assisted liposuction segment generated USD 285.1 million in 2025. This technique remains one of the most widely used methods due to its established clinical reliability, procedural simplicity, and predictable outcomes. It operates through manual fat removal using a cannula connected to a vacuum system, making it a trusted approach in aesthetic fat reduction procedures. Its long-standing use in clinical practice has strengthened surgeon familiarity, reducing training complexity and ensuring consistent results. Cost efficiency and operational ease further contribute to its widespread acceptance across healthcare facilities seeking dependable and economical body contouring solutions.

North America Liposuction Devices Market accounted for a 33.1% share in 2025. Market growth in this region is largely supported by the increasing prevalence of obesity, particularly in the United States, which is driving higher demand for surgical fat reduction procedures. Rising awareness regarding body aesthetics, health risks associated with obesity, and lifestyle improvement trends is further contributing to market expansion. The growing focus on wellness and cosmetic enhancement, combined with strong healthcare infrastructure and access to advanced surgical technologies, continues to support sustained regional demand for liposuction procedures.

Prominent companies operating in the Global Liposuction Devices Market include Johnson & Johnson, InMode, Sciton, Sisram Medical, Cynosure, MicroAire, Euromi, INVAMED, Human Med AG, INTERmedic Arfran, LHbiomed, MOLLER Medical GmbH, Bausch Health Companies, NOUVAG AG, and Vitruvian Partners. Companies in the liposuction devices market are increasingly focusing on product innovation through integration of advanced energy-based technologies such as laser, ultrasound, and radiofrequency to improve precision and patient outcomes. They are expanding their portfolios with minimally invasive and combination treatment solutions that enhance fat removal and skin tightening simultaneously. Strategic collaborations with hospitals and cosmetic clinics are strengthening distribution networks and increasing procedural adoption. Manufacturers are also investing in research and development to improve device safety, efficiency, and recovery time.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Product type trends
    • 2.2.2 Technology trends
    • 2.2.3 End use trends
    • 2.2.4 Regional trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing preference for minimally invasive procedures
      • 3.2.1.2 Growing prevalence of chronic diseases
      • 3.2.1.3 Rapid technological advancements in liposuction devices
      • 3.2.1.4 Growing geriatric population
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Low awareness and availability of alternative treatment method
      • 3.2.2.2 High treatment cost
    • 3.2.3 Market opportunities
      • 3.2.3.1 Rising adoption in emerging markets
      • 3.2.3.2 Integration of liposuction with skin-tightening and contouring technologies
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
      • 3.5.1.1 Energy-based, minimally invasive liposuction systems (RF, laser, ultrasound-assisted)
      • 3.5.1.2 Power-assisted and ergonomically optimized liposuction platforms
    • 3.5.2 Emerging technologies
      • 3.5.2.1 AI-enabled treatment planning and real-time procedural monitoring
      • 3.5.2.2 Smart, connected, and multifunctional liposuction devices
  • 3.6 Future market trends (Driven by primary research)
  • 3.7 Impact of AI and Generative AI on the market (Driven by primary research)
  • 3.8 Pricing analysis, 2025
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 Asia Pacific
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Standalone
  • 5.3 Portable

Chapter 6 Market Estimates and Forecast, By Technology, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Tumescent liposuction
  • 6.3 Ultrasound-assisted liposuction (UAL)
  • 6.4 Laser-assisted liposuction (LAL)
  • 6.5 Power-assisted liposuction (PAL)
  • 6.6 BodyJet or water assisted liposuction (WAL)
  • 6.7 Suction-assisted liposuction (SAL)
  • 6.8 Other technologies

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Cosmetic surgical centers
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Bausch Health Companies
  • 9.2 Cynosure
  • 9.3 Euromi
  • 9.4 Human Med AG
  • 9.5 InMode
  • 9.6 INTERmedic Arfran
  • 9.7 INVAMED
  • 9.8 Johnson & Johnson
  • 9.9 LHbiomed
  • 9.10 MicroAire
  • 9.11 MOLLER Medical GmbH
  • 9.12 NOUVAG AG
  • 9.13 Sciton
  • 9.14 Sisram Medical
  • 9.15 Vitruvian Partners